Literature DB >> 17970889

Systemic ciclosporin and tacrolimus in dermatology.

V Madan1, C E M Griffiths.   

Abstract

Ciclosporin and tacrolimus are calcineurin inhibiting immunosuppressant agents useful in the treatment of immune-mediated inflammatory dermatoses. Available data and clinical experience demonstrate ciclosporin's efficacy in treating psoriasis, atopic dermatitis, pyoderma gangrenosum, lichen planus, autoimmune bullous disease (in combination with corticosteroids), recalcitrant chronic idiopathic urticaria, and chronic dermatitis of the hands and feet. Although the role of topical tacrolimus in atopic dermatitis is well established, such experience with the oral formulation of tacrolimus has been limited. However, there are several case studies and anecdotal reports of the successful use of oral tacrolimus in various dermatoses. In this article we discuss the utility of systemic ciclosporin and tacrolimus in dermatology.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17970889     DOI: 10.1111/j.1529-8019.2007.00137.x

Source DB:  PubMed          Journal:  Dermatol Ther        ISSN: 1396-0296            Impact factor:   2.851


  12 in total

Review 1.  Management of itch in atopic dermatitis.

Authors:  Judith Hong; Joerg Buddenkotte; Timothy G Berger; Martin Steinhoff
Journal:  Semin Cutan Med Surg       Date:  2011-06

Review 2.  Pharmacogenomics in dermatology: tools for understanding gene-drug associations.

Authors:  Roxana Daneshjou; Rachel Huddart; Teri E Klein; Russ B Altman
Journal:  Semin Cutan Med Surg       Date:  2019-03-01

3.  The epithelial cell-derived atopic dermatitis cytokine TSLP activates neurons to induce itch.

Authors:  Sarah R Wilson; Lydia Thé; Lyn M Batia; Katherine Beattie; George E Katibah; Shannan P McClain; Maurizio Pellegrino; Daniel M Estandian; Diana M Bautista
Journal:  Cell       Date:  2013-10-03       Impact factor: 41.582

Review 4.  Systemic therapy of atopic dermatitis in children.

Authors:  Giampaolo Ricci; Arianna Dondi; Annalisa Patrizi; Massimo Masi
Journal:  Drugs       Date:  2009       Impact factor: 9.546

Review 5.  The pro-inflammatory role of TGFβ1: a paradox?

Authors:  Gangwen Han; Fulun Li; Tej Pratap Singh; Peter Wolf; Xiao-Jing Wang
Journal:  Int J Biol Sci       Date:  2012-01-01       Impact factor: 6.580

6.  An Elastomeric Polymer Matrix, PEUU-Tac, Delivers Bioactive Tacrolimus Transdurally to the CNS in Rat.

Authors:  Yolandi van der Merwe; Anne E Faust; Ian Conner; Xinzhu Gu; Firuz Feturi; Wenchen Zhao; Bianca Leonard; Souvik Roy; Vijay S Gorantla; Raman Venkataramanan; Kia M Washington; William R Wagner; Michael B Steketee
Journal:  EBioMedicine       Date:  2017-11-24       Impact factor: 8.143

7.  A Herbal Formula, Atofreellage, Ameliorates Atopic Dermatitis-Like Skin Lesions in an NC/Nga Mouse Model.

Authors:  Won-Yong Kim; Hyeong-Geug Kim; Hye-Won Lee; Jin-Seok Lee; Hwi-Jin Im; Hyo-Seon Kim; Sung-Bae Lee; Chang-Gue Son
Journal:  Molecules       Date:  2015-12-25       Impact factor: 4.411

Review 8.  Clinical application of development of nonantibiotic macrolides that correct inflammation-driven immune dysfunction in inflammatory skin diseases.

Authors:  Carmen Rodriguez-Cerdeira; Elena Sanchez-Blanco; Alberto Molares-Vila
Journal:  Mediators Inflamm       Date:  2012-11-01       Impact factor: 4.711

9.  Clinical, Quality of Life, Patient Adherence, and Safety Outcomes of Short-Course (12 Weeks) Treatment with Cyclosporine in Patients with Severe Psoriasis (the Practice Study).

Authors:  Sandra Swimberghe; Pierre-Dominique Ghislain; Evis Daci; Katrien Allewaert; Kris Denhaerynck; Christine Hermans; Christy Pacheco; Stefaan Vancayzeele; Karen Macdonald; Ivo Abraham
Journal:  Ann Dermatol       Date:  2013-02-14       Impact factor: 1.444

Review 10.  Consensus Conference on Clinical Management of pediatric Atopic Dermatitis.

Authors:  Elena Galli; Iria Neri; Giampaolo Ricci; Ermanno Baldo; Maurizio Barone; Anna Belloni Fortina; Roberto Bernardini; Irene Berti; Carlo Caffarelli; Elisabetta Calamelli; Lucetta Capra; Rossella Carello; Francesca Cipriani; Pasquale Comberiati; Andrea Diociaiuti; Maya El Hachem; Elena Fontana; Michaela Gruber; Ellen Haddock; Nunzia Maiello; Paolo Meglio; Annalisa Patrizi; Diego Peroni; Dorella Scarponi; Ingrid Wielander; Lawrence F Eichenfield
Journal:  Ital J Pediatr       Date:  2016-03-02       Impact factor: 2.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.